Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine.
Izzet DoganNail PaksoySezai VatanseverAdnan AydınerPublished in: European journal of breast health (2023)
metastatic disease, and young age.